Brief Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2010; 16(45): 5732-5738
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5732
Table 1 Characteristics of patients, relatives and control group subjects n (%)
CD (n = 64)CD relatives (n = 25)UC (n = 63)UC relatives (n = 28)Control (n = 34)
Sex
Male28 (43.8)9 (36.0)32 (50.8)11 (39.3)15 (44.1)
Female36 (56.2)16 (64.0)31 (49.2)17 (60.7)19 (55.9)
Age (yr, mean ± SD)37.93 ± 14.0132.12 ± 14.3138.74 ± 13.1335.35 ± 17.0738.58 ± 15.09
Disease duration (yr, mean ± SD)4.37 ± 3.614.03 ± 3.66
Disease location (CD)
Colon2 (3.1)
Ileum26 (40.6)
Ileocolonic36 (56.3)
Disease location (UC)
Proctitis9 (14.3)
Distal involvement24 (38.1)
Left colon invol9 (14.3)
Diffuse2 (3.2)
Pancolitis19 (30.2)
Disease type (CD)
Stricturing7 (10.9)
Penetrating6 (9.4)
Inflammatory51 (79.7)
Medications (for CD and UC)
No medication5 (7.8)5 (7.9)
5-ASA57 (89.06)57 (90.4)
Steroids5 (7.8)5 (7.9)
AZA13 (20.3)8 (12.6)
Antibiotics1 (1.6)3 (4.7)